scientifyRESEARCH
research funding database

This opportunity is currently closed.

Sign up for Content alerts to stay informed when this or related funding opportunities are posted.

RESEARCH FUNDING

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (USA)

Share

Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange plus symbol appears between the two logos.
Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange play symbol appears between the two logos. An arrow mark points to the logos.

The Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21) research grant funded by the National Institutes of Health (NIH) supports clinical trials that can be completed within a limited timeframe and budget. The clinical trial should be designed to address the prevention or reduction of symptoms and improve outcomes and function in patients with rheumatic, musculoskeletal, or skin conditions or diseases. Applicants must be program directors or principal investigators in a U.S.- based institution. Individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and women are encouraged to apply. The grant covers direct costs of up to $400,000 over a three-year period.

Funding Opportunity Announcement (FOA) Number: PAR-21-045.

Applications are due on November 3, 2023

Full application due:
November 3, 2023

non member

More related info for you

Register for free

Don´t have an account?

Start with our free trial to enjoy our 7 days of unlimited grant access and our premium features.

or, Choose a plan to subscribe to our premium membership.

Be the first to know

Sign-up for Personalized Grant alerts

Logo3

Sign-up for our
monthly research
funding newsletter

You can unsubscribe at any time.